SK Biopharmaceuticals launches epilepsy drug in France

SK Biopharmaceuticals launches epilepsy drug in France

South Korean SK Biopharmaceuticals Co. said on Friday that its treatment of epilepsy "Cenobamate" has been approved for sale in France.The company l...

Korea approves Daewoong Pharmaceutical's diabetes drug

Korea approves Daewoong Pharmaceutical's diabetes drug

DAEWOONG PHARMACEUTICAL has received domestic approval for its diabetes drug Envlo with the active ingredient enavogliflozin, the second straight ye...

MBK to buy Medit at lower price than Carlyle-GS bid

MBK to buy Medit at lower price than Carlyle-GS bid

MBK Partners, a leading Asian private equity firm, is set to buy Medit Corp. at a lower price than a bid from the US PE giant The Carlyle Group-led ...

Seoul reclaims spot as Japanese tourists' top destination after 11 yrs: HIS

Seoul reclaims spot as Japanese tourists' top destination after 11 yrs: HIS

Seoul has become the top destination for Japanese tourists for the first time since 2011, according to Japan’s leading travel agency HIS Gro...

Spectrum to push back launch date of Hanmi-developed drug Poziotinib

Spectrum to push back launch date of Hanmi-developed drug Poziotinib

Hanmi Pharmaceutical Co. announced Friday that California-based Spectrum Pharmaceuticals Inc. received a Complete Response Letter (CRL) from the US ...

Nexon named preferred bidder for 50% of office tower from KTCU

Nexon named preferred bidder for 50% of office tower from KTCU

Gaming giant Nexon Co. is set to acquire a 50% stake in the Autoway Tower, an office building in Seoul's Gangnam business district, from the Korean ...

Mezzion Pharma to try again for US FDA approval of drug

Mezzion Pharma to try again for US FDA approval of drug

South Korea's Mezzion Pharma will seek to get the oral medicine Udenafil to treat side effects from heart surgery, planning to clinical trials in th...

Sale of Korean dental scanner maker Medit fails

Sale of Korean dental scanner maker Medit fails

The sale of South Korea's dental scanner manufacturer Medit will undergo a reset as the preferred bidder, a consortium led by GS Holdings and the US...

No more ineffective drugs due to resistance

No more ineffective drugs due to resistance

L-Base is a pharmaceutical startup specializing in developing drugs for those who become resistant to existing cancer treatments. This year, the Minis...

Moderna to stay ahead in mRNA technology: CSO Melissa Moore

Moderna to stay ahead in mRNA technology: CSO Melissa Moore

CAMBRIDGE, MA – The COVID-19 coronavirus disease has been a curse for many people and companies around the world over the past couple of years...

SillaJen shares jump as exchange maintains listing, allows resumed trade

SillaJen shares jump as exchange maintains listing, allows resumed trade

Shares in South Korea’s scandal-hit biotechnological company SillaJen Inc. soared on Thursday after the local exchange decided to maintain the...

Korean corporate bond issuance hits 2022 monthly low in September

Korean corporate bond issuance hits 2022 monthly low in September

South Korean corporate bond issuance in September hit a monthly low this year on souring investor sentiment due to interest rate hikes.Corporate bon...

Average is over; microsegment consumers, professor says

Average is over; microsegment consumers, professor says

The phrase “Average is over” topped the list of 10 key phrases suggested by a renowned Korean consumer behavior professor to predict 202...

Sanofi, Korean biotech Lemonex ink material transfer agreement

Sanofi, Korean biotech Lemonex ink material transfer agreement

South Korean biotech Lemonex Inc. has signed a material transfer agreement (MTA) with global pharmaceutical giant Sanofi S.A. to use the Korean bi...

Hanmi’s anti-cancer drug Rolontis gets FDA approval; US sale via Spectrum

Hanmi’s anti-cancer drug Rolontis gets FDA approval; US sale via Spectrum

South Korea’s Hanmi Pharmaceutical Co. said on Tuesday that Rolontis, an anti-cancer drug it has jointly developed with its US partner, has ob...

Korea eyes $3.8 billion in Redback armored vehicle exports to Australia

Korea eyes $3.8 billion in Redback armored vehicle exports to Australia

South Korea is expected to clinch a deal to export more than 5 trillion won ($3.8 billion) worth of armored vehicles to Australia, which is strength...

Korean teens prefer TikTok over KakaoTalk, says survey

Korean teens prefer TikTok over KakaoTalk, says survey

South Korean teens appear to prefer to do their social networking on TikTok over KakaoTalk, as short-form videos surge in popularity worldwide. ...

Korean bio firms look to pills, patches for people who fear needles

Korean bio firms look to pills, patches for people who fear needles

Getting shots of a drug or vaccine over a long period is not easy for many people.That's probably why global biopharmaceutical companies and biotech...

Celltrion Healthcare logs record-high Q2 revenue on back of Remsima

Celltrion Healthcare logs record-high Q2 revenue on back of Remsima

Celltrion Healthcare Co., South Korean biopharmaceutical giant Celltrion Inc.’s global marketing affiliate, posted its record-high second-quar...

MZers become key consumers of ergonomic office chairs, Sidiz says

MZers become key consumers of ergonomic office chairs, Sidiz says

Ergonomic office chairs are drawing heightened interest from millennials and Generation Zers in South Korea, according to the country’s leadin...

TiumBio inks licensing deal with China's Hansoh for endometriosis drug

TiumBio inks licensing deal with China's Hansoh for endometriosis drug

South Korean biotech TiumBio Co. has signed a technology transfer agreement of its endometriosis and uterine myoma treatment candidate with China&rs...

Brookfield likely to beat KKR for $800 mn Korean gas facility

Brookfield likely to beat KKR for $800 mn Korean gas facility

Brookfield Asset Management has entered talks with South Korea's SK Materials Airplus Inc. to buy the latter's industrial gas facility, after its pr...

Hanwha Aerospace, Hanwha Defense likely to merge

Hanwha Aerospace, Hanwha Defense likely to merge

Hanwha, the South Korean chemicals-to-financial conglomerate, has been a key player in the M&A market with a series of conspicuous acquisitions ...

SK Biopharmaceuticals signs epilepsy drug deal with Brazil’s Eurofarma

SK Biopharmaceuticals signs epilepsy drug deal with Brazil’s Eurofarma

South Korea’s SK Biopharmaceuticals Co. has signed a deal to license out its technology for Cenobamate, an antiepileptic drug, to Brazil&rsquo...

Korean firms eye alternative assets for safer investments, survey finds

Korean firms eye alternative assets for safer investments, survey finds

South Korean corporates are increasingly eyeing alternative assets seeking downside protection amid interest rate hikes and equity and bond price dr...

Korean biotech firms fold COVID-19 therapeutics development businesses

Korean biotech firms fold COVID-19 therapeutics development businesses

A string of South Korean pharmaceutical and biotech companies are waving the white flag when it comes to developing COVID-19 treatments. As the...

1 in 4 biotech firms struggles with decreasing cash reserves

1 in 4 biotech firms struggles with decreasing cash reserves

South Korea’s biotechnology firms – public and private alike –  are facing increasingly negative financial conditions. T...

Pharma companies jump into $3 bn pet care market

Pharma companies jump into $3 bn pet care market

South Korean pharmaceutical companies are jumping into the animal medicine and diagnostics market to target the rapidly growing pet care market, whi...

KG-led consortium named preferred buyer of Ssangyong Motor

KG-led consortium named preferred buyer of Ssangyong Motor

A consortium led by chemicals-to-steel conglomerate KG Group has been named the preferred buyer of South Korea’s troubled sport utility vehicl...

LG Chem receives FDA nod for CUE-102 cancer treatment phase 1 trials

LG Chem receives FDA nod for CUE-102 cancer treatment phase 1 trials

LG Chem Life Sciences, the biopharmaceutical unit of LG Chem Ltd., has received the US Food and Drug Administration’s approval for phase 1 cli...

Allianz-backed Koh Young’s brain surgery robot set for US debut by End-August Roborock’s privacy policy fuels data leak fears over Chinese goods Sale of $1.5 bn Pangyo Tech 1, overseen by Mirae Asset, draws strong bids from global PEFs Kia to make, sell China-launched EV5 in Korea to keep top spot Samsung Asset leads H1 AUM rankings amid ETF boom